All stock lists
Alaunos Therapeutics, Inc. (NASDAQ:TCRT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.13-0.15 (-6.58%)
Insider Score
––Not scored
TCRT Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TCRT analyst forecast
Best analysts covering TCRT
No firm covering TCRT has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TCRT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2023-08-15 |
| — | Laidlaw & Co. | Hold | — | — | Downgraded | 2023-08-14 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2023-05-14 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2022-05-03 |
| — | Raymond James | Market Perform | — | — | Reiterated | 2021-11-08 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2021-08-09 |
| — | Raymond James | Outperform | — | — | Reiterated | 2021-05-06 |
| — | Jefferies | Hold | — | — | Downgraded | 2021-03-11 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2021-02-28 |
| — | Raymond James | Outperform | — | — | Reiterated | 2020-03-02 |
| — | Raymond James | Outperform | — | — | Upgraded | 2018-11-14 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2018-06-17 |
| — | Wells Fargo | Market Perform | — | — | Upgraded | 2016-08-09 |
| — | BMO Capital | Market Perform | — | — | Downgraded | 2015-06-21 |
| — | Mizuho | Neutral | — | — | Downgraded | 2015-03-09 |
| — | BMO Capital | Outperform | — | — | Upgraded | 2015-01-13 |
| — | Piper Sandler | Neutral | — | — | Upgraded | 2014-03-03 |
| — | Brinson Patrick | Market Perform | — | — | Downgraded | 2013-03-26 |
| — | Jefferies | Hold | — | — | Reiterated | 2013-03-25 |
| — | BMO Capital | Underperform | — | — | Downgraded | 2013-03-25 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2013-03-25 |
| — | Piper Sandler | Underweight | — | — | Downgraded | 2013-03-25 |
| — | Jefferies | Hold | — | — | Downgraded | 2012-12-11 |
| — | Jefferies | Buy | — | — | Reiterated | 2012-03-01 |
TCRT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-31 | -3.69 | -0.40 | $3K | $3K |
| 2026-05-15 | 0.00 | -0.59 | $0 | $0 |
| 2026-08-14 | 0.00 | -0.41 | $0 | $0 |
| 2026-11-17 | -15.75 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.